Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2)

Abstract Introduction The Aiming High in Eczema/Atopic Dermatitis (AHEAD) guidelines recommend achieving minimal disease activity (MDA) in atopic dermatitis (AD), defined as simultaneous achievement of optimal treatment targets for at least one clinician- and one patient-reported outcome (ClinRO + P...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Jonathan I. Silverberg, Melinda Gooderham, Norito Katoh, Valeria Aoki, Andrew E. Pink, Yousef Binamer, Brad Glick, Petra Staubach, Brian Calimlim, Chao Li, Ayman Grada, Alvaro Moreira, Wan-Ju Lee, Andreas Wollenberg
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Adis, Springer Healthcare 2025-07-01
Schriftenreihe:	Dermatology and Therapy
Schlagworte:	Atopic dermatitis Minimal disease activity Quality of life Clinician reported outcome Patient reported outcome Upadacitinib
Online-Zugang:	https://doi.org/10.1007/s13555-025-01485-0
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!